JPRN-UMIN000027255招募中未知
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes - Efficacy and safety of dulaglutide in the treatment of type 2 diabetes
Department of nephrology, Matsunami general hospital0 个研究点目标入组 30 人开始时间: 2017年5月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with gastrointestinal bleeding, malignant tumor, liver cirrhosis, and thyroid function abnormalities.
研究者
相似试验
已完成
不适用
Safety and efficacy of dulaglutide therapy for the inpatient management of general medicine patients with type 2 diabetesType 2 diabetesJPRN-UMIN000025006Ichinomiyanishi hospital40
已完成
不适用
Efficacy and safety of dulaglutide when used instead of exenatide extended-release in type 2 diabetic patientsType 2 diabetes mellitusJPRN-UMIN000019031Haga Diabetes Clinic40
已完成
不适用
Efficacy and safety of dulaglutide when used instead of sitagliptin in type 2 diabetic patientsType 2 diabetes mellitusJPRN-UMIN000023245Iwasaki Naika Clinic40
未知
不适用
Comparison of the efficacy and safety of dulaglutide in combination with insulin compared with insulin alone in daibetes patients who are receiving high dose glucocorticoids therapy: a randomized,open-label trialDiabetes mellitusJPRN-UMIN000020037Kanagawa Cardiovascular and Respiratory Center30
已完成
不适用
Safety and Efficacy of dulaglutide therapy for perioperative glycaemic controltype2 diabetesJPRN-UMIN000024342Ichinomiyanishi hospital40